MRK vs HCA
By Alex · Tickerpine
Merck & Co., Inc. vs HCA Healthcare, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | MRK | HCA |
|---|---|---|
| Price | $128.66 | $391.68 |
| Market cap | $317.77B | $86.89B |
| P/E ratio | 36.2 | 13.5 |
| ROE | 18.94% | — |
| Profit margin | 13.59% | 8.89% |
| Revenue growth | 4.90% | 4.30% |
| Dividend yield | 2.64% | 0.80% |
| Beta | 0.22 | 1.13 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
MRK vs HCA in plain English
- MRK is the bigger company — about 3.7× the market cap of HCA.
- HCA is cheaper on earnings (P/E 13.5 vs 36.2).
- MRK is growing revenue faster (5% vs 4%).
- MRK has the higher dividend yield (2.64% vs 0.80%).
How would $1,000 have done in each?
MRK return calculator
See what $1,000 in Merck & Co., Inc. would be worth today.
HCA return calculator
See what $1,000 in HCA Healthcare, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.